Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

FGFR2-triggered signalling in regulation of ER/PR interdependence - molecular mechanism and predictive value for patients with luminal A breast cancer

2018/30/E/NZ3/00222

Keywords:

ER PR FGFR2 breast cancer

Descriptors:

  • NZ3_1: Cell biology
  • NZ3_7: Signal transduction
  • NZ5_3: Pathogenesis of human diseases

Panel:

NZ3 - Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology

Host institution :

Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

woj. pomorskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr hab. Rafał Sądej 

Number of co-investigators in the project: 5

Call: SONATA BIS 8 - announced on 2018-06-15

Amount awarded: 2 499 000 PLN

Project start date (Y-m-d): 2019-10-01

Project end date (Y-m-d): 2025-09-30

Project duration:: 60 months (the same as in the proposal)

Project status: Pending project

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

  • Publication in academic press/journals (3)
  1. FGF7/FGFR2-JunB signalling counteracts the effect of progesterone in luminal breast cancer
    Authors:
    Kamil Mieczkowski, Kamila Kitowska, Marcin Braun, Barbara Galikowska-Bogut, Monika Gorska-Arcisz, Dominika Piasecka, Konrad Stawiski, Anna J Zaczek, Dariusz Nejc, Radzisław Kordek, Hanna M Romanska, Rafal Sadej
    Academic press:
    Molecular Oncology (rok: 2022, tom: 16, strony: 2823-2842), Wydawca: Wiley
    Status:
    Published
    DOI:
    10.1002/1878-0261.13274 - link to the publication
  2. Hormonal Receptor Status Determines Prognostic Significance of FGFR2 in Invasive Breast Carcinoma
    Authors:
    Braun M, Piasecka D, Tomasik B, Mieczkowski K, Stawiski K, Zielinska A, Kopczynski J, Nejc D, Kordek R, Sadej R, Romanska HM
    Academic press:
    Cancers (rok: 2020, tom: 12, strony: 2714), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/cancers12092713 - link to the publication
  3. A 'Real-Life' Experience on Automated Digital Image Analysis of FGFR2 Immunohistochemistry in Breast Cancer
    Authors:
    Braun M, Piasecka D, Bobrowski M, Kordek R, Sadej R, Romanska HM
    Academic press:
    Diagnostics (rok: 2020, tom: 10, strony: 1060), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/diagnostics10121060 - link to the publication